Breaking News Instant updates and real-time market news.

NVS

Novartis

$83.48

-0.19 (-0.23%)

, APDN

Applied DNA Sciences

$1.23

0.04 (3.36%)

04:55
08/31/18
08/31
04:55
08/31/18
04:55

Cambridge Healthtech Institute to hold a summit

5th Annual Immuno-Oncology Summit to be held in Boston on August 27-31.

NVS

Novartis

$83.48

-0.19 (-0.23%)

APDN

Applied DNA Sciences

$1.23

0.04 (3.36%)

LMNX

Luminex

$28.01

-0.16 (-0.57%)

PKI

PerkinElmer

$92.64

2.59 (2.88%)

  • 06

    Sep

  • 12

    Sep

NVS Novartis
$83.48

-0.19 (-0.23%)

08/29/18
JPMS
08/29/18
UPGRADE
Target $75
JPMS
Overweight
JPMorgan upgrades Glaukos after 'main competitor' pulls product
As previously reported, JPMorgan analyst Robert Marcus upgraded Glaukos (GKOS) to Overweight from Neutral, calling Alcon's (NVS) voluntary withdrawal of its micro-stent from the market a "significant win" that opens up an opportunity for Glaukos to take back principally all of the sales being generated by CyPass. Stating that he's always been a firm believer in Glaukos' pipeline and technology, Marcus said competition had been the main factor keeping him on the sidelines. Now that its "main competitor" is out of the way, he sees Glaukos having a meaningful opportunity to recapture share and lead the market. Marcus raised his price target on the stock to $75 from $42.
08/30/18
BMOC
08/30/18
NO CHANGE
Target $59
BMOC
Market Perform
Glaukos price target raised to $59 from $44 at BMO Capital
BMO Capital analyst Joanne Wuensch raised her price target on Glaukos (GKOS) to $59 after the stock price spiked up 40% above $62 yesterday following Novartis' (NVS) Alcon unit withdrawal of the CyPass micro-stent from the market due to safety concerns. The analyst keeps her Market Perform rating however, saying her conversations with physicians suggest that the CyPass cessation does not appear to be a "class effect" and that it will likely return at some stage. Wuensch added that Glaukos's iStent may not necessarily capture all of Alcon's market share, stating that "different devices are right for different patients".
08/30/18
WELS
08/30/18
NO CHANGE
Target $74
WELS
Outperform
Glaukos price target raised to $74 from $50 at Wells Fargo
Wells Fargo analyst Larry Biegelsen raised his price target for Glaukos (GKOS) to $74 from $50, while reiterating an Outperform rating on the shares. The analyst notes that Novartis (NVS) stated it was removing its CyPass micro invasive glaucoma surgery device from the global market due to 5-year data, which showed statistically significant endothelial cell loss for CyPass compared to the group, who underwent cataract surgery alone. The analyst believes the issue is CyPass-specific and expects Glaukos to materially benefit from Alcon's exit beginning in Q4 and years ahead.
08/29/18
SPHN
08/29/18
NO CHANGE
Target $57
SPHN
Overweight
Glaukos price target raised to $57 at Stephens after Novartis withdraws CyPass
Stephens analyst Chris Cooley raised his price target on Glaukos (GKOS) shares to $57 from $50 after Novartis' (NVS) Alcon unit withdrew the CyPass micro-stent from the market due to safety concerns. He estimates $40M-$50M in annual sales are now "in play" and see Glaukos as the most likely beneficiary, Cooley tells investors. He maintains an Overweight rating on Glaukos shares, which are up $17.35, or 39%, to $62.15 in pre-market trading.
APDN Applied DNA Sciences
$1.23

0.04 (3.36%)

04/23/18
MAXM
04/23/18
INITIATION
Target $5
MAXM
Buy
Applied DNA Sciences assumed with a Buy at Maxim
Maxim analyst Anthony Vendetti assumed coverage of Applied DNA Sciences with a Buy rating and $5 price target. The rating and price target are unchanged from Maxim's prior coverage under analyst Brian Kinstlinger.
LMNX Luminex
$28.01

-0.16 (-0.57%)

05/07/18
DBAB
05/07/18
UPGRADE
Target $22
DBAB
Hold
Luminex upgraded to Hold from Sell at Deutsche Bank
Deutsche Bank analyst Dan Leonard upgraded Luminex to Hold and raised his price target for the shares to $22 from $19. The analyst views the risk/reward as balanced at current share levels.
PKI PerkinElmer
$92.64

2.59 (2.88%)

09/26/17
GSCO
09/26/17
INITIATION
Target $67
GSCO
Neutral
PerkinElmer assumed with a Neutral at Goldman Sachs
Goldman analyst Patrick Donnelly assumed coverage on PerkinElmer with a Neutral and $67 price target. The analyst expects below peer growth to continue and believes managements operating profit margin goal of 22% by 2020 is aggressive.
08/30/18
CLVD
08/30/18
UPGRADE
CLVD
Buy
PerkinElmer upgraded to Buy from Neutral at Cleveland Research
01/03/18
EVER
01/03/18
INITIATION
Target $77
EVER
In Line
PerkinElmer initiated with an In Line at Evercore ISI
Evercore ISI analyst Ross Muken initiated PerkinElmer with an In Line rating and $77 price target.
12/19/17
BOFA
12/19/17
UPGRADE
Target $78
BOFA
Neutral
PerkinElmer upgraded to Neutral from Underperform at BofA/Merrill
BofA/Merrill analyst Derik De Bruin upgraded PerkinElmer to Neutral and raised its price target to $78 from $70 ahead ot the pending $1.3B Eurolmmun acquisition. De Bruin said PerkinElmer has been pruning non-core and slower businesses and Eurolmmun is a key step in the portfolio transition with its solid and price competitive autoimmune testing business.

TODAY'S FREE FLY STORIES

$DJU

DJ Utility Average

$0.00

(0.00%)

08:20
04/26/19
04/26
08:20
04/26/19
08:20
Technical Analysis
DJ Utility Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DJX

Dow Jones Industrial Average

$0.00

(0.00%)

08:20
04/26/19
04/26
08:20
04/26/19
08:20
Technical Analysis
Dow Jones Industrial Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IYT

iShares Transportation Average

$194.95

-4.58 (-2.30%)

08:20
04/26/19
04/26
08:20
04/26/19
08:20
Technical Analysis
iShares Transportation Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLK

Technology Select Sector SPDR

$78.85

-0.03 (-0.04%)

08:19
04/26/19
04/26
08:19
04/26/19
08:19
Technical Analysis
Technology Select Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLE

Energy Select Sector SPDR

$67.07

-0.23 (-0.34%)

08:19
04/26/19
04/26
08:19
04/26/19
08:19
Technical Analysis
Energy Select Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLY

Consumer Discretionary Sector SPDR

$119.70

-0.65 (-0.54%)

08:19
04/26/19
04/26
08:19
04/26/19
08:19
Technical Analysis
Consumer Discretionary Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLB

S&P Select Materials SPDR

$56.60

-0.73 (-1.27%)

08:19
04/26/19
04/26
08:19
04/26/19
08:19
Technical Analysis
S&P Select Materials SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLU

Utilities SPDR

$58.03

0.245 (0.42%)

08:18
04/26/19
04/26
08:18
04/26/19
08:18
Technical Analysis
Utilities SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLP

Consumer Staples Sector SPDR

$56.47

-0.36 (-0.63%)

08:18
04/26/19
04/26
08:18
04/26/19
08:18
Technical Analysis
Consumer Staples Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLV

Health Care Select Sector SPDR

$88.19

0.97 (1.11%)

08:18
04/26/19
04/26
08:18
04/26/19
08:18
Technical Analysis
Health Care Select Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IWM

iShares Trust Russell 2000 Index Fund

$156.75

-1.27 (-0.80%)

08:18
04/26/19
04/26
08:18
04/26/19
08:18
Technical Analysis
iShares Trust Russell 2000 Index Fund: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GT

Goodyear Tire

$19.56

-0.54 (-2.69%)

08:17
04/26/19
04/26
08:17
04/26/19
08:17
Hot Stocks
Goodyear Tire CEO says 'we gained momentum in the U.S. during the quarter' »

"We gained momentum…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

DIA

Diamonds Fund ETF

$264.58

-1.32 (-0.50%)

08:17
04/26/19
04/26
08:17
04/26/19
08:17
Technical Analysis
Diamonds Fund ETF: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPY

SPDR S&P 500 ETF Trust

$292.12

-0.1 (-0.03%)

08:17
04/26/19
04/26
08:17
04/26/19
08:17
Technical Analysis
SPDR S&P 500 ETF Trust: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MRCY

Mercury Systems

$72.52

-0.53 (-0.73%)

08:17
04/26/19
04/26
08:17
04/26/19
08:17
Recommendations
Mercury Systems analyst commentary at Canaccord »

Mercury Systems price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Apr

  • 05

    Jun

XLF

Financial Select Sector

$27.46

0.07 (0.26%)

08:17
04/26/19
04/26
08:17
04/26/19
08:17
Technical Analysis
Financial Select Sector: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GT

Goodyear Tire

$19.56

-0.54 (-2.69%)

08:17
04/26/19
04/26
08:17
04/26/19
08:17
Hot Stocks
Goodyear Tire reports Q1 tire unit volumes totaled 38M, down 3% y/y »

Tire unit volumes totaled…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

WCN

Waste Connections

$91.18

1.895 (2.12%)

08:17
04/26/19
04/26
08:17
04/26/19
08:17
Recommendations
Waste Connections analyst commentary at BMO Capital »

Waste Connections price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    May

  • 17

    May

  • 05

    Jun

SMH

Market Vectors Semiconductor

$117.30

-2.22 (-1.86%)

08:16
04/26/19
04/26
08:16
04/26/19
08:16
Technical Analysis
Market Vectors Semiconductor: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QQQ

Invesco QQQ Trust

$190.42

0.74 (0.39%)

08:16
04/26/19
04/26
08:16
04/26/19
08:16
Technical Analysis
Invesco QQQ Trust: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$COMP

Nasdaq Composite

$0.00

(0.00%)

08:16
04/26/19
04/26
08:16
04/26/19
08:16
Technical Analysis
Nasdaq Composite: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMZN

Amazon.com

$1,902.53

1.81 (0.10%)

08:16
04/26/19
04/26
08:16
04/26/19
08:16
Recommendations
Amazon.com analyst commentary at Morgan Stanley »

Amazon 1-day shipping a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    May

  • 22

    May

  • 03

    Jun

NDX

Nasdaq 100 Index

$0.00

(0.00%)

08:16
04/26/19
04/26
08:16
04/26/19
08:16
Technical Analysis
Nasdaq 100 Index: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GT

Goodyear Tire

$19.56

-0.54 (-2.69%)

08:15
04/26/19
04/26
08:15
04/26/19
08:15
Earnings
Goodyear Tire reports Q1 adjusted EPS 19c, consensus 6c »

Reports Q1 revenue $3.6B,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

08:15
04/26/19
04/26
08:15
04/26/19
08:15
General news
U.S. Q1 GDP preview: »

U.S. Q1 GDP preview:…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.